Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

24,446 total articles

Moomoo Expands Crypto Trading to Texas and Launches Direct Crypto Transfers, Advancing Unified Multi-Asset Investing

Moomoo Expands Crypto Trading to Texas and Launches Direct Crypto Transfers, Advancing Unified Multi-Asset Investing

Moomoo Technologies Inc., a Nasdaq-listed global investment and trading platform, announced the expansion of its cryptocurrency trading services to Texas along with the launch of a Direct Crypto Deposit & Withdraw feature for U.S. users. This move broadens crypto accessibility to multiple U.S. states and integrates seamless multi-asset investing by…

Oncolytics Biotech® to Present Data at ASCO 2026 Reinforcing Pelareorep’s Potential Across Gastrointestinal Tumors

Oncolytics Biotech® to Present Data at ASCO 2026 Reinforcing Pelareorep’s Potential Across Gastrointestinal Tumors

Oncolytics Biotech Inc. announced that new translational data from its GOBLET and AWARE-1 clinical trials involving pelareorep will be presented at the 2026 ASCO Annual Meeting. The data demonstrates pelareorep's mechanism of activating immune responses in difficult-to-treat cancers with KRAS mutations, specifically pancreatic and breast cancers. T…

20/20 Biolabs Commences Emergency Planning for Ebola & Hantavirus Lab Testing if Outbreak Creates Overflow Demand

20/20 Biolabs Commences Emergency Planning for Ebola & Hantavirus Lab Testing if Outbreak Creates Overflow Demand

20/20 Biolabs announces contingency plans to develop Ebola and Hantavirus PCR testing in its CAP-accredited CLIA laboratory to support potential overflow demand from public health laboratories. Drawing on its extensive COVID-19 testing experience, the company is engaging with global PCR test kit developers and evaluating existing equipment for rapi…

FibroBiologics Presents Preclinical Data Demonstrating Durable Immunomodulation in Psoriasis at the Society for Investigative Dermatology 2026 Annual Meeting

FibroBiologics Presents Preclinical Data Demonstrating Durable Immunomodulation in Psoriasis at the Society for Investigative Dermatology 2026 Annual Meeting

FibroBiologics, Inc., a clinical-stage biotechnology company, announced preclinical data from its CYPS317 program for psoriasis presented at the Society for Investigative Dermatology 2026 Annual Meeting. The data demonstrated that fibroblast spheroids provided sustained therapeutic benefits and a favorable safety profile in psoriasis mouse models b…

Ebola Outbreak “Spreading at Alarming Speed,” WHO Warns — Growing Global Health Emergencies Highlight Rising Need for TOMI’s SteraMist Technology

Ebola Outbreak “Spreading at Alarming Speed,” WHO Warns — Growing Global Health Emergencies Highlight Rising Need for TOMI’s SteraMist Technology

TOMI Environmental Solutions underscores the urgent need for advanced decontamination technologies as the WHO warns of a rapidly spreading Ebola outbreak in Central Africa involving the dangerous Bundibugyo strain. Leveraging its proven SteraMist system, TOMI positions itself as a key player in infectious disease containment efforts globally, servi…

Global Mofy Announces Milestone for Gausspeed: AI Platform Developed in Conjunction with NVIDIA Omniverse Connects with Digital Asset Libraries

Global Mofy Announces Milestone for Gausspeed: AI Platform Developed in Conjunction with NVIDIA Omniverse Connects with Digital Asset Libraries

Global Mofy AI Limited announced a significant development milestone for its generative AI platform, Gausspeed, by integrating it with its vast 3D digital asset library containing over 150,000 high-precision assets. Utilizing NVIDIA Omniverse and OpenUSD architecture, the connection enhances AI-driven digital content production capabilities and wor…

Cycurion Acquires Secuvant, Supercharging AI-Driven Cybersecurity with Automated, Scalable Threat Defense – Perfectly Complements HavenX Platform

Cycurion Acquires Secuvant, Supercharging AI-Driven Cybersecurity with Automated, Scalable Threat Defense – Perfectly Complements HavenX Platform

Cycurion, Inc. has acquired cybersecurity firm Secuvant, LLC, enhancing its AI-powered cybersecurity platform with advanced threat detection, risk management, and compliance capabilities. The acquisition adds approximately $3 million in annual revenue and integrates Secuvant's proprietary Cyber7 methodology and Panoptic platform, complementing Cycu…

"Ark Plan" Renamed to "Binance Plan": Baiya International Group Inc. Establishes $1 Million Strategic BNB Position

"Ark Plan" Renamed to "Binance Plan": Baiya International Group Inc. Establishes $1 Million Strategic BNB Position

Baiya International Group Inc., a Nasdaq-listed HR technology company, has rebranded its digital asset strategy from 'Ark Plan' to 'Binance Plan' following strong shareholder support. The company deployed $1 million to acquire Binance Coin (BNB) as a strategic core position and activated four algorithmic trading strategies to optimize returns. Furt…

WRAP® Developing Directional Light Scenarios and Non-Lethal Response (NLR) Technologies for WrapReality® VR Training Platform

WRAP® Developing Directional Light Scenarios and Non-Lethal Response (NLR) Technologies for WrapReality® VR Training Platform

Wrap Technologies, Inc. is enhancing its WrapReality® virtual reality training platform by developing low-light and directional light scenarios to better simulate nighttime patrol conditions. This expansion aims to improve law enforcement officers' decision-making and use of non-lethal force options in low-visibility environments. The company is al…

Global Ship Lease Reports Results for the First Quarter of 2026

Global Ship Lease Reports Results for the First Quarter of 2026

Global Ship Lease, a leading containership owner, announced solid first quarter 2026 results including operating revenues of $198.1 million, net income of $91.4 million, and adjusted EBITDA of $133.2 million. The company has locked in forward contract coverage for 100% of 2026 and 86% of 2027, totaling over $2 billion in contracted revenues. They d…

SBC Medical and BLEZ ASIA Celebrate Opening of New Aesthetic Dermatology Section at BLEZ CLINIC in Bangkok

SBC Medical and BLEZ ASIA Celebrate Opening of New Aesthetic Dermatology Section at BLEZ CLINIC in Bangkok

SBC Medical Group Holdings Incorporated, a Nasdaq-listed U.S. medical services company, announced the opening of a new aesthetic dermatology section at BLEZ CLINIC in Bangkok through its consulting partner BLEZ ASIA. The new section, launching services in June 2026, will offer Japanese-standard aesthetic treatments such as pico laser for pigmentati…

SunPower Adds $5M to Recent $41M Offering

SunPower Adds $5M to Recent $41M Offering

SunPower Inc. has closed an additional $5 million private placement on its April senior convertible debenture notes, bringing total funding to $46 million. The funds will support intra-quarter liquidity for general corporate purposes. The company is focused on reducing overhead costs from prior acquisitions and aims to achieve steady-state cashflow…

ABM to Announce Second Quarter 2026 Financial Results

ABM to Announce Second Quarter 2026 Financial Results

ABM Industries Incorporated announced the release of its fiscal second quarter 2026 financial results on June 5, 2026, prior to market opening. The company will host a conference call and webcast for investors to discuss the results, with a replay available for 90 days. ABM is a leading provider of integrated facility solutions serving diverse sect…

Assembly Biosciences Announces Pricing of $100 Million Offering of Common Stock and Pre-Funded Warrants

Assembly Biosciences Announces Pricing of $100 Million Offering of Common Stock and Pre-Funded Warrants

Assembly Biosciences, a Nasdaq-listed biotechnology company, announced the pricing of a $100 million offering of common stock and pre-funded warrants. The proceeds are intended to support the clinical development of its pipeline candidates targeting serious viral and liver diseases. The offering attracted participation from new and existing investo…

Assembly Biosciences Announces Expansion of ABI-6250 Clinical Development Into Cholestatic Liver Diseases

Assembly Biosciences Announces Expansion of ABI-6250 Clinical Development Into Cholestatic Liver Diseases

Assembly Biosciences, Inc. announced the expansion of its clinical development program for ABI-6250, an oral entry inhibitor originally targeted for chronic hepatitis delta virus (HDV) infection, to include primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC). A Phase 2 study focusing on these cholestatic liver diseases is exp…